Confidence re Coming Weeks, page-114

This statement makes mention of multiple facilities being used here and overseas:

"Biotron is aware of shareholder interest in the progress of the clinical trials.
It is, however, imperative that the remaining laboratory work is completed with all attention to detail
and in accordance with international guidelines for undertaking such studies.
They are complex and require careful handling in specialised facilities here in Australia and overseas."

"The work is in its final stage and everyone associated with the trials is focused on completing the analyses as fast as possible. Release of headline data is expected in coming weeks."